alpha-aminopyridine has been researched along with Osteoporosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, XT; Guo, JX; Li, CL; Li, TY; Lv, F; Wang, XF; Wang, YJ | 1 |
| Chen, W; Fang, Z; Guan, H; Li, F; Li, J; Zhang, Y | 1 |
| Anderson, N; Andrade, K; Fornetti, J; McHale, M; Miller, SC; Randall, RL; Waltz, SE; Welm, AL; Zhao, L | 1 |
| Strohmeier, M | 1 |
| Miethe, D; Pittrow, D; Ringe, JD; Wegscheider, K | 1 |
| Adams, PC; Azzarano, LM; Bondinell, WE; Bradbeer, J; Cousins, RD; Drake, FH; Erhard, KF; Gowen, M; Haltiwanger, RC; Hoffman, SJ; Huffman, WF; Hwang, SM; Jakas, DR; James, IE; Keenan, RM; Ku, TW; Lark, MW; Lechowska, B; Miller, WH; Newlander, KA; Rieman, DJ; Ross, ST; Stroup, GB; Vasko-Moser, JA; Zembryki, DL | 1 |
| Bradbeer, JN; Drake, FH; Erhard, KF; Gowen, M; Huffman, WF; Hwang, SM; James, IE; Lark, MW; Mathur, A; Miller, WH; Newlander, KA; Rieman, DJ; Ross, ST; Salyers, KL; Smith, BR; Stroup, GB | 1 |
1 review(s) available for alpha-aminopyridine and Osteoporosis
| Article | Year |
|---|---|
[IGOST guideline for pharmacotherapy of low back pain].
Topics: Amines; Aminopyridines; Analgesics; Analgesics, Opioid; Anti-Anxiety Agents; Antidepressive Agents; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Gabapentin; gamma-Aminobutyric Acid; Humans; Low Back Pain; Methocarbamol; Muscle Relaxants, Central; Neuromuscular Agents; Osteoporosis; Practice Guidelines as Topic; Tolperisone | 2010 |
1 trial(s) available for alpha-aminopyridine and Osteoporosis
| Article | Year |
|---|---|
Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis.
Topics: Aged; Aminopyridines; Analgesics; Female; Humans; Male; Middle Aged; Multivariate Analysis; Osteoporosis; Pain; Pain Measurement; Prospective Studies | 2003 |
5 other study(ies) available for alpha-aminopyridine and Osteoporosis
| Article | Year |
|---|---|
Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
Topics: Aminopyridines; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Cancellous Bone; Disease Models, Animal; Lipopolysaccharides; Male; Osteoclasts; Osteoporosis; Pyrroles; Rats, Sprague-Dawley; Receptor, Macrophage Colony-Stimulating Factor; Tibia | 2019 |
Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Bone Density Conservation Agents; Cell Differentiation; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred C57BL; Osteoclasts; Osteoporosis; Ovariectomy; Treatment Outcome | 2015 |
RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.
Topics: Aminopyridines; Animals; Bone and Bones; Estrogens; Female; Humans; Mice; Mice, Transgenic; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Osteoblasts; Osteoclasts; Osteoporosis; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyridones; Receptor Protein-Tyrosine Kinases; Signal Transduction; Treatment Outcome | 2017 |
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.
Topics: Acetates; Administration, Oral; Aminopyridines; Animals; Benzodiazepinones; Biological Availability; Disease Models, Animal; Kinetics; Osteoporosis; Rats; Receptors, Vitronectin; Time Factors | 1999 |
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Topics: Acetates; Administration, Oral; Aminopyridines; Animals; Bone Resorption; Cell Adhesion; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Infusions, Intravenous; Integrins; Osteoporosis; Ovariectomy; Parathyroidectomy; Platelet Aggregation; Protein Binding; Rats; Receptors, Vitronectin; Thyroidectomy; Time Factors | 1999 |